For many people, the holidays mean large family dinners with filling sides, sweet treats, and festive drinks — all things for ...

Novo Nordisk said on Friday it will begin a new trial of its experimental next-generation CagriSema drug in the first half of ...

Novo Nordisk plans a new trial for its experimental drug, CagriSema, in 2025 after recent trials failed to meet weight-loss expectations. Despite aiding patients to reduce weight by 22.7%, it fell ...

Medical payments coverage, also known as MedPay, is an additional coverage option for auto insurance policies in most states. In the event of a car accident, this coverage can help pay for medical ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

Propofol dosing and titration is variable, based on the patient's tolerance to the drug. Profound changes can occur rapidly. A patient can go from breathing normally to a full respiratory arrest ...

The company plans to leverage research and development incentives from the Australian Government to offset the trial costs.

Shares in Novo Nordisk have fallen by more than a quarter after the Ozempic maker revealed a set of underwhelming results in ...

Novo Nordisk shares on the NYSE rose over 5% in premarket trading Monday, reversing some losses from Friday’s plunge that ...

After titration to optimum dose (range 100-400mg), patients received medication for 12 weeks. Main outcome measures and results: Efficacy evaluations included: Western Ontario and McMaster ...

Various medications that treat narcolepsy are available, and treatment plans can vary based on individual symptoms and other factors. Healthcare providers often start with one medication but may need ...